As many as 65 children in Uzbekistan died after being given the Indian cough and cold syrup "Doc-1 Max", a representative of the Uzbek Supreme Court said on August 11. Officials in the country have previously only referred to around 20 victims.
A criminal case centred on the deaths caused by the contaminated medicine began on August 11 in Uzbekistan. The court heard that 21 people, all Uzbek citizens apart from one citizen of India, who is the director of Quramax Medikal, were being held in the case.
Charges pressed include tax evasion, the production, manufacture, acquisition, storage, transportation for sale or sale of substandard or falsified medicines or medical products, abuse of office, negligence, forgery and bribery.
In December 2022, the cough syrup Doc-1 Max, produced by Indian company Marion Biotech, was associated with the deaths of at least 20 children in Uzbekistan.
The Indian regulator later cancelled the manufacturing licence of Marion Biotech, which exported the medicines to Uzbekistan, and arrested some of its employees.
China has emerged as the foremost purchaser of Russian seaborne crude, outstripping India's import volumes, according to data from energy cargo tracker Vortexa. March figures just released point ... more
Central banks bought 77 tonnes of gold in August, marking an increase of 38% m/m, according to the World Gold Council (WGC). Analysts say central bank demand continues to dominate the ... more
The G20 has adopted a consensus declaration on its attitude to the war in Ukraine, Indian Prime Minister Narendra Modi announced early on in the meeting of the world’s leading economies in New ... more